Roche awarded WHO prequalification for the cobas® HPV test, increasing access to cervical cancer screening tools in low and lower-middle income countries Every year, over 600,000 women worldwide are diagnosed with cervical cancer and over...

Case Western Reserve-led research team identifies biomarker to identify which patients with oropharyngeal cancer will benefit from therapy ‘de-escalation’ CLEVELAND—A Case Western Reserve University-led team of scientists has...

Not all organizations agree on mammogram guidelines. For instance, the U.S. Preventive Services Task Force mammogram guidelines recommend women begin screening at age 50. The American Cancer Society, the National Comprehensive Cancer Network...

Experience Tomorrow's Innovation Visit Leica Biosystems at CAP 2015, Booth 320 October 4-6 in Nashville, TN When you attend CAP 2015, visit booth 320 and see how Leica Biosystems is advancing workflow...

The US Food and Drug Administration recently approved the use of a human papillomavirus (HPV) test as a primary cervical cancer screening test in women as young as 25 years, yet physicians are unlikely to ditch the Papanicolaou (Pap) test soon,...

Courtesy of colLABoration: A Sharing of Insights for Enhancing Laboratories and Laboratory Informatics Advisory Panel Recommends HPV as First-line Screen An advisory panel for the Medical Devices Committee of the FDA voted unanimously to...